In total dollars and number of investors, the CTAN investment in Xeris Pharmaceuticals is the organization’s third-largest to date. About 30 members have invested in Xeris, according to CTAN Executive Director Claire England.
Pharmaceutical company backed by Austin angel investors files for IPO
